Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.24.0.1
Equity (Tables)
 6 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Black-Scholes Option Pricing Model The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following assumptions:
    Six Months Ended
December 31,
2023		  
Exercise price   $ 0.59 – 0.97  
Expected term (years)     4.00 – 4.75  
Volatility     71 – 75 %
Risk-free interest rate     4.42 – 4.66 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 0.35  
Schedule of Compensation Expense Related to Our Stock-Based Awards Compensation expense related to our stock-based awards described above was as follows (in thousands):
    Three Months Ended
December 31,		     Six months ended
December 31,		  
    2023     2022     2023     2022  
Research and Development   $ 119     $ 883     $ 652     $ 2,051  
General and Administrative   $ 135     $ 1,012     $ 1,423     $ 2,193  
Cost of Revenue   $ 62      
—
     $ 124          
Total   $ 316     $ 1,895     $ 2,199     $ 4,244  

 
Schedule of Unrecognized Stock-Based Compensation Expense and Weighted-Average Years Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands):
    As of December 31, 2023  
    Unrecognized
stock-based
compensation		     Weighted-
average years
to be recognized		  
Options   $ 974       1.73  
Restricted stock units   $ 7,519       1.99